| Innsideraksjer | 25 637 643 shares |
| Totale insidere | 40 |
Insider Sentiment Score
Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.
Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.
Oppdateringsfrekvens: Daglig
Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.
Officer Sentiment Score
Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.
Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.
Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.
Oppdateringsfrekvens: Daglig
Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.
Nøkkelindikatorer for insidere
Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.
For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).
Prosent av aksjeflyt kjøpt av insidere (rang)
N/A
Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.
Diagram over innsidehandel
Bicycle Therapeutics plc - Depositary Receipt (Common Stock) insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.
Insiderliste og lønnsomhetsmålinger
Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.
See our leaderboard of most profitable insider traders.
| Innsider | Gjennomsnittlig fortjeneste (%) | Aksjer eid |
Splitt justert |
|---|---|---|---|
|
Aquila Investments Iv
10% Owner -
|
1 957 961 | 1 957 961 | |
| Michael Anstey Director - [D] | 1 751 437 | 1 751 437 | |
| Santiago Arroyo CHIEF DEVELOPMENT OFFICER - [O] | 69 057 | 69 057 | |
|
Baker Bros. Advisors Lp
Director, 10% Owner -
[D]
|
9 999 674 | 9 999 674 | |
| Kate Bingham Director - [D] | 38 708 | 38 708 | |
| Janice Bourque Director - [D] | 23 000 | 23 000 | |
|
Innovation Capital (Jersey) Ltd Cambridge
10% Owner -
|
1 751 437 | 1 751 437 | |
| Nigel Crockett CHIEF BUSINESS OFFICER - [O] | 51 053 | 51 053 | |
| Roger D Dansey Director - [D] | 12 500 | 12 500 | |
|
Plc Glaxosmithkline
10% Owner -
|
1 910 531 | 1 910 531 | |
| Jose-Carlos Gutierrez-Ramos Director - [D] | 23 000 | 23 000 | |
| Deborah Harland Director - [D] | 1 915 275 | 1 915 275 | |
| Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF - [O] | 53 825 | 53 825 |
| Innsider | Gjennomsnittlig fortjeneste (%) | Aksjer eid |
Splitt justert |
|---|---|---|---|
| Herve Hoppenot Director - [D] | 12 500 | 12 500 | |
| Veronica GH Jordan Director - [D] | 16 750 | 16 750 | |
| Lee Kalowski President and CFO - [O] | 30 309 | 30 309 | |
| Nicholas Keen CHIEF SCIENTIFIC OFFICER - [O] | 62 024 | 62 024 | |
| Richard N Kender Director - [D] | 23 000 | 23 000 | |
| Kevin Lee CHIEF EXECUTIVE OFFICER, Director - [D] [O] | 480 804 | 480 804 | |
| Pierre Legault Director - [D] | 46 000 | 46 000 | |
| Peter Brian Leone | 43 269 | ||
| Alistair Milnes CHIEF OPERATING OFFICER - [O] | 95 502 | 95 502 | |
| Carolyn Ng Director - [D] | 1 427 151 | 1 427 151 | |
|
Ag Novartis
10% Owner -
|
1 769 641 | 1 769 641 | |
|
Bioventures Ltd Novartis
10% Owner -
|
1 769 641 | 1 769 641 | |
| Alessandro Riva Director - [D] | 12 500 | 12 500 |
| Innsider | Gjennomsnittlig fortjeneste (%) | Aksjer eid |
Splitt justert |
|---|---|---|---|
|
Sv Life Sciences Fund V Lp
10% Owner -
|
39 637 | 39 637 | |
|
SV Life Sciences Fund V (GP), LP
10% Owner -
|
39 637 | 39 637 | |
|
SV Life Sciences Fund V Strategic Partners, L.P.
10% Owner -
|
39 637 | 39 637 | |
|
Svlsf V, Llc
10% Owner -
|
39 637 | 39 637 | |
| Sands Stephen H. Director - [D] | 17 393 | 17 393 | |
| Michael Skynner CHIEF TECHNOLOGY OFFICER - [O] | 120 079 | 120 079 | |
| Dominic Smethurst Chief Medical Officer - [O] | 36 699 | 36 699 | |
| Robert Charles Swanton Director - [D] | 3 089 | 3 089 | |
|
Capital Management Hk Ltd Tybourne
10% Owner -
|
1 957 961 | 1 957 961 | |
| Travis Alvin Thompson CHIEF ACCOUNTING OFFICER - [O] | 31 521 | 31 521 | |
|
Vertex Global Healthcare Fund I Pte Ltd.
10% Owner -
|
1 621 168 | 1 621 168 | |
| Eric Westin Chief Medical Officer - [O] | 2 305 | 2 305 | |
| Gregory Paul Winter Director - [D] | 186 927 | 186 927 | |
| Alethia Young Chief Financial Officer - [O] | 45 186 | 45 186 |
Report errors via our new Insider Auditing Tool
Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse
I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.
Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse
I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .
Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.
Transaksjonshistorikk
Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.
| Fil dato |
Handels dato |
Skjema | Innsider | Ticker | Verdipapirnavn | Kode | Direkte | Utøvelses pris |
Enhets pris |
Enheter endret |
Verdi endret (1K) |
Gjenværende Opsjoner |
Gjenværende Aksjer |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-10 | 2025-09-08 | 4 | Hoppenot Herve | BCYC | Ordinary Shares | D | 12 500 | 12 500 | ||||||
| 2025-09-10 | 2025-09-08 | 4 | DANSEY ROGER D | BCYC | Ordinary Shares | D | 12 500 | 12 500 | ||||||
| 2025-08-14 | 2025-08-12 | 4 | Swanton Robert Charles | BCYC | Ordinary Shares | D | 12 500 | 15 589 | ||||||
| 2025-08-14 | 3 | Swanton Robert Charles | BCYC | Ordinary Shares | D | 3 089 | ||||||||
| 2025-07-07 | 2025-07-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 7,0900 | −204 | −1 | 45 186 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7,4400 | −100 | −1 | 31 521 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7,0900 | −206 | −1 | 31 621 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7,4400 | −248 | −2 | 53 825 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7,0900 | −474 | −3 | 54 073 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7,4400 | −966 | −7 | 95 502 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7,0900 | −1 149 | −8 | 96 468 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7,4400 | −966 | −7 | 120 079 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7,0900 | −825 | −6 | 121 045 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7,4400 | −3 193 | −24 | 480 804 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7,0900 | −2 268 | −16 | 483 997 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7,4800 | −109 | −1 | 31 827 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8,0200 | −210 | −2 | 31 936 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7,4800 | −266 | −2 | 54 547 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 8,0200 | −467 | −4 | 54 813 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7,4800 | −3 432 | −26 | 486 265 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 8,0200 | −2 237 | −18 | 489 697 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7,4800 | −1 038 | −8 | 97 617 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 8,0200 | −1 133 | −9 | 98 655 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7,4800 | −1 038 | −8 | 121 870 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 8,0200 | −814 | −7 | 122 908 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 8,0200 | −215 | −2 | 45 390 | ||||
| 2025-03-27 | 2025-03-25 | 4 | Riva Alessandro | BCYC | Ordinary Shares | D | 12 500 | 12 500 | ||||||
| 2025-03-27 | 3 | Westin Eric | BCYC | Ordinary Shares | D | 2 305 | ||||||||
| 2025-01-06 | 2025-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 14,7500 | −936 | −14 | 99 788 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 14,0900 | −4 578 | −65 | 100 724 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 35 000 | 105 302 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 6 250 | 23 000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Sands Stephen H. | BCYC | Ordinary Shares | D | 5 393 | 17 393 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,7500 | −3 092 | −46 | 491 934 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0900 | −9 038 | −127 | 495 026 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 123 200 | 504 064 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 14,7500 | −239 | −4 | 55 280 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 14,0900 | −1 879 | −26 | 55 519 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 35 000 | 57 398 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 14,7500 | −936 | −14 | 123 722 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 14,0900 | −3 287 | −46 | 124 658 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 35 000 | 127 945 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 14,7500 | −936 | −14 | 51 053 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 14,0900 | −2 583 | −36 | 51 989 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 8 750 | 54 572 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 14,0900 | −4 943 | −70 | 69 057 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 35 000 | 74 000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 14,0900 | −1 395 | −20 | 45 605 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 35 000 | 47 000 | ||||||
| 2025-01-06 | 2025-01-06 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 15,0000 | −2 686 | −40 | 32 146 | ||||
| 2025-01-06 | 2025-01-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 14,7500 | −159 | −2 | 34 832 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 14,0900 | −1 750 | −25 | 34 991 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 17 500 | 36 741 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 12 500 | 46 000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 6 250 | 23 000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 6 250 | 186 927 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 6 250 | 23 000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 4 400 | 9 999 674 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 4 400 | 918 483 | ||||||
| 2024-12-17 | 2024-12-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 15,3418 | 457 631 | 7 021 | 9 995 274 | ||||
| 2024-12-17 | 2024-12-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 15,3418 | 42 369 | 650 | 914 083 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,8040 | 566 814 | 7 824 | 9 537 643 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,8040 | 52 656 | 727 | 871 714 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,7242 | 244 587 | 3 357 | 8 970 829 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,7242 | 22 722 | 312 | 819 058 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,6288 | 59 995 | 818 | 8 726 242 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,6288 | 5 573 | 76 | 796 336 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,4979 | 30 241 | 408 | 8 666 247 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,4979 | 2 809 | 38 | 790 763 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 24,8200 | −231 | −6 | 19 241 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 24,7700 | −209 | −5 | 19 472 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,2100 | −3 241 | −82 | 19 681 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,0500 | −1 109 | −28 | 22 922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 9,8200 | 1 109 | 11 | 24 031 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,0100 | −154 | −4 | 22 922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8,2100 | 154 | 1 | 23 076 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,0500 | −1 312 | −33 | 22 922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 1,8700 | 1 312 | 2 | 24 234 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 22,2600 | −972 | −22 | 70 302 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 22,2600 | −972 | −22 | 92 945 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 22,2600 | −247 | −5 | 22 398 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 22,2600 | −3 212 | −71 | 380 864 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 22,2600 | −153 | −3 | 22 922 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 22,2600 | −972 | −22 | 45 822 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 19,6400 | −246 | −5 | 22 645 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 19,6400 | −967 | −19 | 71 274 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 19,6400 | −3 194 | −63 | 384 076 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 19,6400 | −967 | −19 | 46 794 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 19,6400 | −779 | −15 | 62 024 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 19,6400 | −148 | −3 | 23 075 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 19,6400 | −967 | −19 | 93 917 | ||||
| 2024-06-20 | 2024-06-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 2 186 686 | 8 636 006 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 196 098 | 787 954 | ||||||
| 2024-04-22 | 2024-04-18 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 12 000 | 6 449 320 | ||||||
| 2024-04-22 | 2024-04-18 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 12 000 | 6 449 320 | ||||||
| 2024-04-18 | 3 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 579 856 | ||||||||
| 2024-04-18 | 3 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 6 437 320 | ||||||||
| 2024-04-12 | 2024-04-11 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 22,4900 | −257 | −6 | 22 891 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 23,8100 | −152 | −4 | 23 223 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 23,8100 | −790 | −19 | 62 803 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 23,8100 | −955 | −23 | 47 761 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 23,8100 | −955 | −23 | 72 241 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 23,8100 | −955 | −23 | 94 884 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 23,8100 | −3 158 | −75 | 387 270 | ||||
| 2024-03-21 | 3 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 23 148 | ||||||||
| 2024-02-21 | 2024-02-20 | 4 | Sands Stephen H. | BCYC | Ordinary Shares | D | 12 000 | 12 000 | ||||||
| 2024-02-08 | 2024-02-06 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 21 660 | 39 000 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 17,5000 | −604 | −11 | 23 375 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 16 000 | 23 979 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 12 000 | 33 500 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 17,5000 | −2 640 | −46 | 63 593 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28 000 | 66 233 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 6 000 | 16 750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 6 000 | 16 750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 6 000 | 180 677 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 6 000 | 16 750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 6 000 | 16 750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 17 340 | 17 340 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 17,5000 | −2 643 | −46 | 48 716 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 22 000 | 51 359 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 17,5000 | −2 643 | −46 | 73 196 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 39 000 | 75 839 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 12 000 | 12 000 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 17,5000 | −8 703 | −152 | 390 428 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 77 000 | 399 131 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 17,5000 | −2 643 | −46 | 95 839 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 28 000 | 98 482 | ||||||
| 2023-10-05 | 2023-10-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 20,0000 | −54 | −1 | 7 979 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 20,0000 | −272 | −5 | 38 233 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 20,0000 | −442 | −9 | 29 359 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 20,0000 | −1 470 | −29 | 322 131 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 20,0000 | −442 | −9 | 36 839 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 20,0000 | −442 | −9 | 70 482 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 25,1000 | −451 | −11 | 29 801 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 25,1000 | −1 498 | −38 | 323 601 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 25,1000 | −451 | −11 | 37 281 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,1000 | −61 | −2 | 8 033 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 25,1000 | −336 | −8 | 38 505 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 25,1000 | −451 | −11 | 70 924 | ||||
| 2023-07-03 | 3 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8 094 | ||||||||
| 2023-04-05 | 2023-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 21,1100 | −447 | −9 | 71 375 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 21,1100 | −319 | −7 | 38 841 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 21,1100 | −447 | −9 | 37 732 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 21,1100 | −376 | −8 | 30 309 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 21,1100 | −1 486 | −31 | 325 099 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 21,1100 | −447 | −9 | 30 252 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 5 750 | 10 750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 5 750 | 10 750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 29,0600 | −1 801 | −52 | 71 822 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 17 500 | 73 623 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29,0600 | −6 000 | −174 | 326 585 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 57 500 | 332 585 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 5 750 | 174 677 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 11 500 | 21 500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 29,0600 | −1 815 | −53 | 30 685 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 17 500 | 32 500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 5 750 | 10 750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 29,0600 | −1 817 | −53 | 39 160 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 17 500 | 40 977 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 29,0600 | −1 801 | −52 | 30 699 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 17 500 | 32 500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 5 750 | 10 750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 29,0600 | −1 801 | −52 | 36 699 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 17 500 | 38 500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 29,0600 | −1 801 | −52 | 38 179 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 17 500 | 39 980 | ||||||
| 2022-03-29 | 2022-03-25 | 4 | Milnes Alistair | BCYC | Employee Stock Option (right to buy) | D | 20,12 | 5 155 | 46 845 | |||||
| 2022-03-29 | 2022-03-25 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 20,1200 | 5 155 | 104 | 22 480 | ||||
| 2022-03-29 | 3/A | Milnes Alistair | BCYC | Ordinary Shares | D | 2 325 | ||||||||
| 2022-01-05 | 2022-01-03 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 60,87 | 10 000 | 10 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 5 000 | 5 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 60,87 | 10 000 | 10 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 5 000 | 168 927 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30 000 | 30 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 15 000 | 56 123 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30 000 | 30 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 15 000 | 21 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 100 000 | 100 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 50 000 | 275 085 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 60,87 | 20 000 | 20 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 10 000 | 10 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 60,87 | 10 000 | 10 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 5 000 | 5 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30 000 | 30 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 15 000 | 15 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30 000 | 30 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 15 000 | 23 477 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Stock Option (right to buy) | D | 60,87 | 10 000 | 10 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 5 000 | 5 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30 000 | 30 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15 000 | 15 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 60,87 | 10 000 | 10 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 5 000 | 5 000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Milnes Alistair | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 100 000 | 100 000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 15 000 | 15 000 | ||||||
| 2021-12-22 | 2021-12-21 | 4 | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14,00 | −15 477 | 161 927 | |||||
| 2021-12-22 | 2021-12-21 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 14,0000 | 15 477 | 217 | 15 477 | ||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,48 | −97 860 | 23 312 | |||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 58,0100 | −97 860 | −5 677 | 0 | ||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,4800 | 97 860 | 830 | 97 860 | ||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,44 | −44 537 | 121 172 | |||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 57,1100 | −44 537 | −2 544 | 0 | ||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,4400 | 44 537 | 376 | 44 537 | ||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,41 | −7 603 | 165 709 | |||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 57,0200 | −7 603 | −434 | 0 | ||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,4100 | 7 603 | 64 | 7 603 | ||||
| 2021-10-18 | 2021-10-18 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60,0000 | −49 | −3 | 225 085 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60,0500 | −320 | −19 | 225 134 | ||||
| 2021-10-18 | 2021-10-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60,0000 | −4 631 | −278 | 225 454 | ||||
| 2021-10-13 | 2021-10-11 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 54,6700 | −598 | −33 | 230 085 | ||||
| 2021-10-13 | 2021-10-11 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 53,7700 | −4 402 | −237 | 230 683 | ||||
| 2021-10-05 | 2021-10-05 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,1000 | −2 178 | −98 | 0 | ||||
| 2021-10-05 | 2021-10-01 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,0000 | −1 188 | −53 | 2 178 | ||||
| 2021-09-27 | 2021-09-23 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 18,55 | −6 000 | 114 000 | |||||
| 2021-09-27 | 2021-09-23 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 18,5500 | 6 000 | 111 | 6 000 | ||||
| 2021-09-17 | 2021-09-16 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,0100 | −1 955 | −88 | 3 366 | ||||
| 2021-09-17 | 2021-09-15 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,0000 | −3 000 | −135 | 5 321 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 9,82 | −10 000 | 50 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 40,0000 | −10 000 | −400 | 0 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 9,8200 | 10 000 | 98 | 10 000 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 40,0000 | −10 000 | −400 | 8 321 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 40,0000 | −5 000 | −200 | 235 085 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −22 890 | 306 252 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 38,0800 | −1 796 | −68 | 240 085 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 37,5200 | −17 098 | −642 | 241 881 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,3800 | −8 191 | −298 | 258 979 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 22 890 | 320 | 267 170 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −10 420 | 329 142 | |||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 37,0800 | −1 272 | −47 | 244 280 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,2300 | −9 953 | −361 | 245 552 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 10 420 | 146 | 255 505 | ||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −1 808 | 339 562 | |||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,0200 | −1 808 | −65 | 245 085 | ||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 1 808 | 25 | 246 893 | ||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 8,73 | −7 950 | 5 768 | |||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 35,1500 | −7 950 | −279 | 0 | ||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 8,7300 | 7 950 | 69 | 7 950 | ||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 8,76 | −550 | 13 718 | |||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 35,0400 | −550 | −19 | 0 | ||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 8,7600 | 550 | 5 | 550 | ||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,60 | −7 500 | 59 774 | |||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 33,0200 | −7 500 | −248 | 0 | ||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,6000 | 7 500 | 12 | 7 500 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,63 | −12 500 | 67 274 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 32,8100 | −300 | −10 | 0 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 32,1300 | −3 204 | −103 | 300 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 31,2400 | −8 996 | −281 | 3 504 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,6300 | 12 500 | 20 | 12 500 | ||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −100 | 341 370 | |||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,0000 | −100 | −4 | 245 085 | ||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 100 | 1 | 245 185 | ||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −4 782 | 341 470 | |||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,0200 | −4 782 | −172 | 245 085 | ||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 4 782 | 67 | 249 867 | ||||
| 2021-07-20 | 2021-07-14 | 4/A | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 34,0076 | −917 | −31 | 38 708 | ||||
| 2021-07-20 | 2021-07-14 | 4/A | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 34,0076 | −43 378 | −1 475 | 1 831 671 | ||||
| 2021-07-20 | 2021-07-13 | 4/A | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 33,5000 | −12 | −0 | 39 625 | ||||
| 2021-07-20 | 2021-07-13 | 4/A | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 33,5000 | −588 | −20 | 1 875 049 | ||||
| 2021-07-16 | 2021-07-14 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 35,0000 | −10 000 | −350 | 18 321 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −609 | 346 252 | |||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,0000 | −609 | −21 | 245 085 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 609 | 9 | 245 694 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −21 970 | 346 861 | |||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,2800 | −21 970 | −753 | 245 085 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 21 970 | 308 | 267 055 | ||||
| 2021-07-15 | 2021-07-14 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 34,0076 | −917 | −31 | 38 708 | ||||
| 2021-07-15 | 2021-07-14 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 34,0076 | −43 378 | −1 475 | 1 831 671 | ||||
| 2021-07-15 | 2021-07-13 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 33,5000 | −12 | −0 | 39 625 | ||||
| 2021-07-15 | 2021-07-13 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 33,5000 | −588 | −20 | 1 875 049 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −8 331 | 368 831 | |||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 35,1600 | −53 | −2 | 245 085 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,8900 | −9 084 | −317 | 245 138 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,8500 | −2 686 | −91 | 254 222 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,9300 | −2 642 | −87 | 256 908 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 8 331 | 117 | 259 550 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −35 446 | 377 162 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,0000 | −11 194 | −381 | 251 219 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,0900 | −5 788 | −192 | 262 413 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,4200 | −21 979 | −713 | 268 201 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 35 446 | 496 | 290 180 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −1 936 | 412 608 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,0400 | −1 936 | −62 | 254 734 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 1 936 | 27 | 256 670 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15,36 | −13 019 | 30 764 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | −19 256 | 38 750 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 11,66 | −40 426 | 62 660 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 33,0900 | −3 121 | −103 | 0 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32,4100 | −69 580 | −2 255 | 3 121 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15,3600 | 13 019 | 200 | 72 701 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9,8200 | 19 256 | 189 | 59 682 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 11,6600 | 40 426 | 471 | 40 426 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15,36 | −974 | 43 783 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | −1 723 | 58 006 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 11,66 | −4 331 | 103 086 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32,0300 | −7 028 | −225 | 0 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15,3600 | 974 | 15 | 7 028 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9,8200 | 1 723 | 17 | 6 054 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 11,6600 | 4 331 | 50 | 4 331 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | −271 | 59 729 | |||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32,0000 | −271 | −9 | 0 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9,8200 | 271 | 3 | 271 | ||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −5 604 | 414 544 | |||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,2300 | −5 604 | −181 | 254 734 | ||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 5 604 | 78 | 260 338 | ||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −1 716 | 420 148 | |||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,1400 | −1 716 | −55 | 254 734 | ||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 1 716 | 24 | 256 450 | ||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −897 | 421 864 | |||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,0300 | −897 | −29 | 254 734 | ||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 897 | 13 | 255 631 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | −3 391 | 422 761 | |||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,1600 | −3 391 | −109 | 254 734 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 3 391 | 47 | 258 125 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | −30 406 | 426 152 | |||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,8800 | −26 635 | −822 | 254 734 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29,8900 | −3 771 | −113 | 281 369 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 30 406 | 426 | 285 140 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | −6 018 | 456 558 | |||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,9500 | −1 609 | −50 | 254 734 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,3500 | −4 409 | −134 | 256 343 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 6 018 | 84 | 260 752 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | −22 495 | 462 576 | |||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,3500 | −200 | −7 | 254 734 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,3000 | −1 460 | −47 | 254 934 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,2200 | −14 348 | −448 | 256 394 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,4300 | −6 487 | −197 | 270 742 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 22 495 | 315 | 277 229 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,4100 | −358 | −11 | 254 734 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,6600 | −6 278 | −192 | 255 092 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 6 636 | 93 | 261 370 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | −6 636 | 485 071 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | −14 545 | 491 707 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,5000 | −13 896 | −438 | 254 734 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,6300 | −4 715 | −144 | 268 630 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 14 545 | 204 | 273 345 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,74 | −24 838 | 173 312 | |||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 32,1300 | −239 | −8 | 0 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 31,4000 | −12 099 | −380 | 239 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 32,0000 | −12 500 | −400 | 12 338 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,7400 | 24 838 | 217 | 24 838 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,83 | −162 | 198 150 | |||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 31,0700 | −162 | −5 | 0 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,8300 | 162 | 1 | 162 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 30,0000 | −10 000 | −300 | 28 321 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,78 | −10 000 | 198 312 | |||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 30,0000 | −10 000 | −300 | 0 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,7800 | 10 000 | 88 | 10 000 | ||||
| 2021-03-19 | 2021-03-17 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Stock Option (right to buy) | D | 27,90 | 32 000 | 32 000 | |||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,85 | −7 784 | 208 312 | |||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 29,0000 | −7 784 | −226 | 0 | ||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,8500 | 7 784 | 69 | 7 784 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,86 | −2 216 | 216 096 | |||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 29,0000 | −2 216 | −64 | 0 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,8600 | 2 216 | 20 | 2 216 | ||||
| 2021-03-16 | 2021-03-15 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28,0000 | −217 | −6 | 38 321 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 29,0000 | −283 | −8 | 38 538 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28,4800 | −9 500 | −271 | 38 821 | ||||
| 2021-02-09 | 2021-02-05 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,0000 | −100 | −3 | 258 800 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,0000 | −351 | −12 | 258 900 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,0200 | −100 | −3 | 259 251 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,3272 | −734 | −23 | 259 351 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,0900 | −100 | −3 | 260 085 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,2193 | −371 | −11 | 260 185 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29,1389 | −4 529 | −132 | 260 556 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,59 | −15 000 | 79 774 | |||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 30,0000 | −15 000 | −450 | 0 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5900 | 15 000 | 24 | 15 000 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,60 | −10 000 | 94 774 | |||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 25,0000 | −10 000 | −250 | 0 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,6000 | 10 000 | 16 | 10 000 | ||||
| 2021-01-15 | 2021-01-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 27,0100 | −5 000 | −135 | 265 085 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 25,0000 | −5 000 | −125 | 270 085 | ||||
| 2021-01-05 | 2021-01-04 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 17,95 | 19 000 | 19 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 27 621 | 27 621 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70 500 | 70 500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 17,95 | 38 000 | 38 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 250 000 | 250 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 17,95 | 19 000 | 19 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70 500 | 70 500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70 500 | 70 500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 17,95 | 19 000 | 19 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70 500 | 70 500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 17,95 | 19 000 | 19 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | BINGHAM KATE | BCYC | Stock Option (right to buy) | D | 17,95 | 19 000 | 19 000 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | −7 500 | 104 774 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 22,5000 | −7 500 | −169 | 0 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 7 500 | 12 | 7 500 | ||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | −530 | 112 274 | |||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20,0000 | −530 | −11 | 0 | ||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 530 | 1 | 530 | ||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | −9 781 | 112 804 | |||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20,0700 | −9 781 | −196 | 0 | ||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 9 781 | 15 | 9 781 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | −17 189 | 122 585 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20,3800 | −213 | −4 | 0 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 19,8200 | −16 976 | −336 | 213 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 17 189 | 27 | 17 189 | ||||
| 2020-09-18 | 2020-07-15 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19,2500 | −78 | −2 | 1 910 531 | ||||
| 2020-09-18 | 2020-07-15 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19,4016 | −3 069 | −60 | 1 910 609 | ||||
| 2020-09-18 | 2020-07-14 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19,2740 | −1 597 | −31 | 1 913 678 | ||||
| 2020-08-25 | 2020-08-21 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 18,55 | 120 000 | 120 000 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14,00 | 177 404 | 177 404 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 14,00 | 283 414 | 283 414 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Skynner Michael | BCYC | Stock Option (Right to Buy) | D | 14,00 | 183 895 | 183 895 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | 506 252 | 506 252 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 14,00 | 116 827 | 116 827 | |||||
| 2020-04-16 | 2020-04-14 | 4 | Winter Gregory Paul | BCYC | Series A Preferred Shares Warrant | D | −71 450 | 71 450 | ||||||
| 2020-04-16 | 2020-04-14 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 71 450 | 163 927 | ||||||
| 2020-02-25 | 2020-02-21 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15,36 | 44 757 | 44 757 | |||||
| 2020-01-06 | 2019-09-26 | 4/A | Crockett Nigel | BCYC | Employee Stock Option (Right to Buy) | D | 11,66 | 107 417 | 107 417 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 9,82 | 8 202 | 8 202 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 9,82 | 16 000 | 16 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 9,82 | 32 000 | 32 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 9,82 | 8 202 | 8 202 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 9,82 | 16 000 | 16 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60 000 | 60 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 9,82 | 16 000 | 16 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60 000 | 60 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60 000 | 60 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60 000 | 60 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 210 000 | 210 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 9,82 | 16 000 | 16 000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | BINGHAM KATE | BCYC | Stock Option (right to buy) | D | 9,82 | 16 000 | 16 000 | |||||
| 2019-12-19 | 2019-12-17 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 8,30 | 32 000 | 32 000 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Bourque Janice | BCYC | Stock Option (Right to Buy) | D | 11,66 | 23 798 | 23 798 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Crockett Nigel | BCYC | Employee Stock Option (Right to Buy) | D | 11,66 | 152 174 | 152 174 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Kender Richard N | BCYC | Stock Option (Right to Buy) | D | 11,66 | 23 798 | 23 798 | |||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Series B2 Preferred Shares Warrants | I | −139 264 | 0 | ||||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 14,0000 | 364 286 | 5 100 | 1 957 961 | ||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 139 264 | 1 593 675 | ||||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 1 454 411 | 1 454 411 | ||||||
| 2019-06-03 | 2019-05-24 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Series B2 Preferred Shares | I | −1 454 411 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B2 Preferred Shares | I | −206 767 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares Warrants | I | −141 668 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares | I | −1 272 733 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 206 767 | 1 427 151 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 141 668 | 1 207 410 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 1 272 733 | 1 081 823 | ||||||
| 2019-05-31 | 2019-05-29 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 14,0000 | 314 286 | 4 400 | 1 751 437 | ||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B2 Preferred Shares | D | −229 741 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B1 Preferred Shares Warrants | D | −125 587 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B1 Preferred Shares | D | −1 081 823 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 229 741 | 1 437 151 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 125 587 | 1 207 410 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 1 081 823 | 1 081 823 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B2 Preferred Shares | D | −206 767 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B1 Preferred Shares Warrants | D | −141 668 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B1 Preferred Shares | D | −1 272 733 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 206 767 | 1 621 168 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 141 668 | 1 414 401 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 1 272 733 | 1 272 733 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14,00 | 177 404 | 177 404 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Skynner Michael | BCYC | Stock Option (Right to Buy) | D | 14,00 | 183 895 | 183 895 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 14,00 | 283 414 | 283 414 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Leone Peter Brian | BCYC | Stock Option (Right to Buy) | D | 14,00 | 43 269 | 43 269 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | 506 252 | 506 252 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 14,00 | 116 827 | 116 827 | |||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Series B1 Preferred Shares | I | −636 366 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Series A Preferred Shares | I | −893 195 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 14,0000 | 385 714 | 5 400 | 1 915 275 | ||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 636 366 | 1 529 561 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 893 195 | 893 195 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series B1 Preferred Shares | I | −13 169 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series A Preferred Shares | I | −18 485 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Series B1 Preferred Shares | I | −623 196 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Series A Preferred Shares | I | −874 709 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 14,0000 | 7 983 | 112 | 39 637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 14,0000 | 377 732 | 5 288 | 1 875 637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 13 169 | 31 654 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 18 485 | 18 485 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 623 196 | 1 497 905 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 874 709 | 874 709 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B2 Preferred Shares | I | 229 741 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B1 Preferred Shares Warrants | I | 125 587 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B1 Preferred Shares | I | 1 081 823 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 14,0000 | 314 286 | 4 400 | 1 751 437 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 229 741 | 1 437 151 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 125 587 | 1 207 410 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 1 081 823 | 1 081 823 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series B1 Preferred Shares | I | −13 169 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series A Preferred Shares | I | −18 485 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Series B1 Preferred Shares | I | −623 196 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Series A Preferred Shares | I | −874 709 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 14,0000 | 7 983 | 112 | 39 637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 14,0000 | 377 732 | 5 288 | 1 875 637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 13 169 | 31 654 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 18 485 | 18 485 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 623 196 | 1 497 905 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 874 709 | 874 709 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B2 Preferred Shares | I | −206 767 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares Warrants | I | −141 668 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares | I | −1 272 733 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 206 767 | 1 621 168 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 141 668 | 1 414 401 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 1 272 733 | 1 272 733 | ||||||
| 2019-05-30 | 2019-05-27 | 4 | NG CAROLYN By Vertex Venture Management PTE LTD. | BCYC | Ordinary Shares | I | 14,0000 | 571 429 | 8 000 | 571 429 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Winter Gregory Paul | BCYC | Series A Preferred Shares | D | −42 870 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 42 870 | 92 477 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series B1 Preferred Shares | D | −636 366 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series A Preferred Shares Warrants | D | −71 450 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series A Preferred Shares | D | −893 195 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 14,0000 | 168 630 | 2 361 | 1 769 641 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 636 366 | 1 601 011 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 71 450 | 964 645 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 893 195 | 893 195 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Series B1 Preferred Shares | I | −445 323 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Series A Preferred Shares | I | −625 049 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 14,0000 | 385 714 | 5 400 | 1 915 275 | ||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 636 366 | 1 529 561 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 893 195 | 893 195 | ||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82 246 | ||||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82 246 | ||||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82 246 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550 170 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550 170 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550 170 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96 642 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96 642 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96 642 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99 214 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99 214 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99 214 |
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)
